In NSCLC, LAT1 expression was significantly associated with gender, tumour size, lymph node metastasis, disease stage, lymphatic permeation, vascular permeation, and pleural involvement. The gene discussed is SLC7A5; the disease is metastatic malignant neoplasm in the lymph nodes.